1. Home
  2. ELTK vs TVGN Comparison

ELTK vs TVGN Comparison

Compare ELTK & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$8.23

Market Cap

53.3M

Sector

Technology

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$7.34

Market Cap

63.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
TVGN
Founded
1970
2020
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
53.3M
63.9M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
ELTK
TVGN
Price
$8.23
$7.34
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5K
15.8K
Earning Date
05-19-2026
05-13-2026
Dividend Yield
2.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$0.14
52 Week High
$12.19
$10.76

Technical Indicators

Market Signals
Indicator
ELTK
TVGN
Relative Strength Index (RSI) 39.14 60.07
Support Level $7.79 $0.47
Resistance Level $9.26 $9.40
Average True Range (ATR) 0.31 0.73
MACD -0.04 -0.08
Stochastic Oscillator 17.37 35.50

Price Performance

Historical Comparison
ELTK
TVGN

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: